Ventolin HFA Related Clinical Trials
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate [Completed]
Preterm Infant Inhaled Albuterol Dosing [Recruiting]
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients [Completed]
Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction [Terminated]
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics [Completed]
The Various Effects of Gaseous Albuterol on Serum Lactate [Recruiting]
Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma [Completed]
A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma [Completed]
Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB) [Completed]
Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD) [Completed]
A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma [Completed]
Continuous Levalbuterol for Treatment of Status Asthmaticus in Children [Completed]
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI) [Completed]
Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax� and ProAir� Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma [Completed]
Safety Study of Albuterol Spiromax® in Subjects With Asthma [Completed]
Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients [Terminated]
Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes [Completed]
Comparison of Single-Dose Efficacy of an Albuterol Breath Activated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered Dose Inhaler (HFA-MDI) (Both Using the Same Hydrofluoroalkane Propellant) in Asthmatics [Completed]
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children [Completed]
A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing [Terminated]
Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma [Completed]
4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma [Terminated]
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma [Completed]
Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma [Completed]
Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension [Recruiting]
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma [Completed]
Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique [Completed]
Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects [Completed]
Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED) [Completed]
Nebulized Albuterol for Congestive Heart Failure Exacerbation [Withdrawn]
Chronic-Dose Safety and Efficacy Study of an Albuterol Metered Dose Inhaler (MDI) Inhaler Using a Hydrofluoroalkane (HFA) Propellant In Pediatric Asthmatics [Completed]
Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma [Completed]
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler) [Completed]
The Effect of Nebulized Albuterol on Donor Oxygenation [Completed]
Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma [Completed]
Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning [Recruiting]
Albuterol in Individuals With Late Onset Pompe Disease (LOPD) [Completed]
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis [Recruiting]
A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma [Completed]
Effect of Nebulized Bronchodilators on Heart Rate [Completed]
A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics [Completed]
A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI) [Completed]
Response to Albuterol Delivered Through an Anti-static Valved Holding Chamber During Nocturnal Bronchospasm [Completed]
Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients [Completed]
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital [Completed]
Hypertonic Saline for Outpatient Bronchiolitis [Recruiting]
Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm [Completed]
Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation [Terminated]
Trial of Epinephrine and Albuterol in Bronchiolitis [Active, not recruiting]
4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma [Completed]
Safety and Efficacy of Albuterol on Motor Function in Individuals With Late-onset Pompe Disease Receiving Enzyme Replacement Therapy [Recruiting]
Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol [Withdrawn]
Inhaled Salbutamol in Elective Caesarean Section [Recruiting]
Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects [Completed]
Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
IPF Drug Deposition Study [Completed]
Exercise Induced Bronchospasm in Children [Completed]
Steroids Helping Albuterol Responders Exclusively [Withdrawn]
Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study [Terminated]
Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol [Completed]
Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma [Completed]
Salbutamol Tolerance Onset [Completed]
Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) [Completed]
Albuterol to Improve Respiratory Strength in SCI [Not yet recruiting]
Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB [Completed]
Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics [Completed]
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma [Completed]
Symbicort Onset of Action 2 [Completed]
A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control [Recruiting]
A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation [Completed]
Symbicort Onset of Action 1 [Completed]
Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD [Completed]
Bronchodilator Responsiveness in Obliterative Bronchiolitis [Completed]
Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol [Completed]
Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD [Completed]
The Effect of High Dose Salbutamol on Muscle Performance [Active, not recruiting]
A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients [Completed]
Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4 [Completed]
A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers [Completed]
Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 [Completed]
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma [Completed]
Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol [Completed]
Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients [Recruiting]
Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease [Completed]
An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs. [Completed]
Effect of the Salbutamol on Mechanical Properties of Respiratory System [Recruiting]
The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia [Completed]
Efficacy Study of SYN006 HFA MDI in Asthma Patients [Completed]
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease [Completed]
Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects [Completed]
Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol [Completed]
Chronic-dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics [Completed]
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma [Completed]
Evaluation of Efficacy and Safety of E004 in Children With Asthma [Completed]
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects [Completed]
|